{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:46:34Z","timestamp":1790700394204,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0213913","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T17:36:51Z","timestamp":1553189811000},"page":"e0213913","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation"],"prefix":"10.1371","volume":"14","author":[{"given":"Elizabeth A.","family":"de Kort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen S.","family":"de Lil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manita E. J.","family":"Bremmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke F. J.","family":"van Groningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M. A.","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerwin","family":"Huls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-725X","authenticated-orcid":true,"given":"Roger J. M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"van Dorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-9701","authenticated-orcid":true,"given":"Walter J. F. M.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"issue":"22","key":"ref1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute Graft-versus-Host Disease\u2014Biologic Process, Prevention, and Therapy","volume":"377","author":"R Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"GB McDonald","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-2006-945530","article-title":"Major complications following hematopoietic stem cell transplantation","volume":"27","author":"B Afessa","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2003-04-1311","article-title":"Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients","volume":"103","author":"WJ Hogan","year":"2004","journal-title":"Blood"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrclinonc.2014.102","article-title":"Current and emerging strategies for the prevention of graft-versus-host disease","volume":"11","author":"SW Choi","year":"2014","journal-title":"Nature reviews Clinical oncology"},{"issue":"3","key":"ref6","first-page":"1331","article-title":"Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays","volume":"22","author":"K Atkinson","year":"1990","journal-title":"Transplant Proc"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/clinchem\/36.10.1841","article-title":"Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel","volume":"36","author":"LM Shaw","year":"1990","journal-title":"Clin Chem"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007691-199412000-00007","article-title":"Cyclosporin A monitoring in Australia: consensus recommendations","volume":"16","author":"RG Morris","year":"1994","journal-title":"Ther Drug Monit"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice","volume":"49","author":"T Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","article-title":"Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases","volume":"101","author":"D Niederwieser","year":"2003","journal-title":"Blood"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003088-198916010-00002","article-title":"Therapeutic drug monitoring of cyclosporin. Practical applications and limitations","volume":"16","author":"V Rodighiero","year":"1989","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbmt.2009.08.010","article-title":"Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"16","author":"F Malard","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"ref13","first-page":"461","article-title":"Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease","volume":"7","author":"D Przepiorka","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198807143190201","article-title":"Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation","volume":"319","author":"GC Yee","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/bmt.2013.139","article-title":"Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival","volume":"49","author":"JR Rogosheske","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/bmt.2015.323","article-title":"Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation","volume":"51","author":"A Ganetsky","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbmt.2011.08.016","article-title":"Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation","volume":"18","author":"R Ram","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1200\/JCO.2005.03.1765","article-title":"Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors","volume":"24","author":"U Hegenbart","year":"2006","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"ML Sorror","year":"2011","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbmt.2013.02.006","article-title":"Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects","volume":"19","author":"R Storb","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bbmt.2016.02.003","article-title":"Addition of 10-Day Decitabine to Fludarabine\/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses","volume":"22","author":"M Cruijsen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"ML Sorror","year":"2005","journal-title":"Blood"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"A Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"P Armand","year":"2012","journal-title":"Blood"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"AC Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"AH Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1200\/JCO.2012.45.0247","article-title":"Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation","volume":"31","author":"R Storb","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"MH Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/bmt.2017.227","article-title":"Recommendations for reporting post-transplant relapse in AML","volume":"53","author":"A Rashidi","year":"2018","journal-title":"Bone marrow transplantation"},{"issue":"Suppl 1","key":"ref30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48","author":"S Iacobelli","year":"2013","journal-title":"Bone marrow transplantation"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"SG Holtan","year":"2015","journal-title":"Blood"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2169\/internalmedicine.52.0019","article-title":"Syndrome of inappropriate antidiuretic hormone secretion induced by tacrolimus following allogeneic cord blood transplantation","volume":"52","author":"Y Arai","year":"2013","journal-title":"Intern Med"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V77.7.1423.1423","article-title":"Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia","volume":"77","author":"A Bacigalupo","year":"1991","journal-title":"Blood"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-99-6-851","article-title":"Cyclosporine nephrotoxicity","volume":"99","author":"WM Bennett","year":"1983","journal-title":"Annals of internal medicine"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"M Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00007890-199103000-00037","article-title":"The effects of age and dosage route on experimental cyclosporine nephrotoxicity","volume":"51","author":"WM Bennett","year":"1991","journal-title":"Transplantation"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"W Xie","year":"2001","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9343(87)90900-4","article-title":"Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine","volume":"83","author":"CH Barton","year":"1987","journal-title":"Am J Med"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ndt\/gfg515","article-title":"Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities","volume":"19","author":"R Higgins","year":"2004","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/s10165-010-0350-2","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone induced by tacrolimus in a patient with systemic lupus erythematosus","volume":"21","author":"K Suemori","year":"2011","journal-title":"Modern rheumatology \/ the Japan Rheumatism Association"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12185-017-2253-x","article-title":"Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation","volume":"106","author":"M Saburi","year":"2017","journal-title":"Int J Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0213913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T11:01:02Z","timestamp":1606906862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0213913"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Remuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0213913","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]}}}